92 results on '"Acosta Á"'
Search Results
2. Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy: Assessment of cohort and method effects
3. Independent component analysis for rectal bleeding prediction following prostate cancer radiotherapy
4. Multi-atlas-based segmentation of prostatic urethra from planning CT imaging to quantify dose distribution in prostate cancer radiotherapy
5. 2403: Specific dose optimization driven by late toxicity subregions in prostate cancer treatment plans
6. 1963: Identifying spatial dose patterns predictive of haematological toxicity after prostate cancer RT
7. 2837: Metabolic profiling of plasma and tissue in breast cancer patients: uncovering therapeutic response
8. 2794: New DL approach for dysphagia analysis in videofluoroscopy swallowing studies in HN cancer patients
9. 2588: Complete Uncertainty Estimation and Quantification In Automatic Prostate Cancer OAR Segmentation
10. Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer
11. Identification of a rectal subregion highly predictive of rectal bleeding in prostate cancer IMRT
12. Quantification of dose uncertainties in cumulated dose estimation compared to planned dose in prostate IMRT
13. OC-0266 Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis. A non-inferiority Trial.
14. PO-1450 Clinical Outcome and Radiologic Changes in SARS-CoV-2 Pneumonia treated with Low-Dose Radiotherapy.
15. OC-0770 Deep Learning-based segmentation of prostatic urethra on CT scans for treatment planning
16. PO-1683 Spatial Characterization of errors in pseudo-CT generation for MRI-only radiotherapy
17. PO-2120 In silico simulation for better prediction of biochemical recurrence in prostate cancer radiotherapy
18. PO-2119 Repeatability of Voxel-Based Analysis pipeline in radiation oncology: a first pilot experiment
19. PO-2095 In silico identification of dose equivalences in hypofractionated prostate cancer radiotherapy
20. PO-1732 Scripts system implementation to improve quality management in radiotherapy
21. PO-1562 Radiotherapy treatment in non melanoma skin cancer (NMSC)
22. PO-1441 Exploring the circulatory metabolic alterations in breast cancer patients
23. PD-0968 Treatment of COVID-19 pneumonia with low-dose radiotherapy in frail patients
24. PD-0326 Alternative DL segmentation approaches for clinical partially-labeled HN data: transformers or Unet?
25. MO-0475 Late toxicity-associated patient-specific subregions in plan optimization for prostate cancer
26. SP-1017 What have we learnt and translation to the clinic?
27. PO-1632 DL-based OAR delineation for Head and Neck Radiotherapy: accuracy versus computational resources
28. PO-1611 Evaluation of synthetic-CT generated from prostate MRI (0.35T) with a 2D+ Pix2Pix method
29. PO-1615 Evaluation of prostate synthetic CTs from 0.35T MR images using different deep training cohort sizes
30. EP-1357: moderate hypofractionated-imrt of prostate bed after radical prostatectom : acute toxicity
31. PO-1978 Chronic and cosmetic toxicity in patients undergoing radiotherapy and breast reconstruction
32. PO-1677 cGAN-based pseudo-CT generation for prostate MRI-only radiotherapy
33. PO-1107 Inflammatory markers in breast cancer patients treated with radiotherapy: Machine Learning approach
34. PH-0216 Volumetric and dosimetric stability of metabolic tumor volume in dose painting of anal cancer
35. PD-0791 VMAT plan complexity in dose painting
36. PP-0117 HDR BT in Non melanoma Skin Cancer: Results and toxicity with different techniques and applicators.
37. PO-0245 HDR Monotherapy/LDR-EBRT/HDR-EBRT in patients with favorable IR prostate cancer: Long term results.
38. PO-0238 LDR-HDR boost in patients with intermediate-risk prostate cancer. A single Institution experience.
39. PO-0237 HDR monotherapy (2 fractions/1,5 Gy) in LR and favorable IR prostate cancer: analysis of toxicity.
40. PO-1551: Deep CNN on PET/CT images for NSCLC automated tumor detection and outcome prediction
41. PO-1535: Machine Learning and Oversampling techniques to predict urinary toxicity after prostate cancer RT
42. PO-1484: MRI only based planning to decrease toxicity in prostate cancer IMRT/IGRT: a dosimetric study
43. PO-1233: Perioperative Radiotherapy with a Moderate Dose-Escalation for Retroperitoneal Sarcoma (RPS).
44. PO-1222: Radiotherapy for non-melanoma skin cancer: three different radiation techniques comparison
45. PO-1176: Ultra-hypofractionated SBRT for localized prostate cancer: single institution experience
46. PO-1104: Effect Of Neoadjuvant Radiochemotherapy On Activity Of Paraoxonase -1 In Rectal Cancer Patients
47. PO-1103: The Energy Metabolism Changes In Rectal Cancer Patients After Neoadjuvant Radiochemotherapy
48. PO-0980: Preliminar evaluation of a new bra for large or pendular breasts irradiation.
49. PO-0975: Retrospective evaluation of clinical outcome and dosimetric aspects in breast cancer reirradiations
50. PH-0283: Machine learning methods to predict rectal bleeding after prostate cancer radiotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.